Avience Biomedicals Limited (NSE:AVIENCE)

India · Delayed Price · Currency is INR

287.40

-2.75 (-0.95%)

At close: Oct 7, 2026

Market Cap	1.58B
Revenue (ttm)	525.16M +417.5%
Net Income	87.53M +1,128.3%
EPS	21.71 +309.9%
Shares Out	5.49M
PE Ratio	13.24
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,800
Open	298.00
Previous Close	290.15
Day's Range	286.70 - 300.00
52-Week Range	208.00 - 414.95
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 16, 2026

About Avience Biomedicals

Avience Biomedicals Limited manufactures and sells Vitro-Diagnostic products and medical devices in India. The company's products include reagents and consumables, such as biochemistry reagents, hematology reagents, immunoassay reagents, electrolyte reagents, and cuvettes, pipette tips, test tubes, microplates, and filters; diagnostic instruments and equipment includes automated biochemistry analysers, hematology analysers, immunoassay analysers, molecular diagnostic instruments, microbiology instruments and electrolyte analyser; rapid test kit... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2019

Employees 65

Stock Exchange National Stock Exchange of India

Ticker Symbol AVIENCE

Full Company Profile

Financial Performance

In fiscal year 2026, Avience Biomedicals's revenue was 525.16 million, an increase of 15.80% compared to the previous year's 453.50 million. Earnings were 87.53 million, an increase of 23.30%.

Financial Statements